SAMRAT PHARMACHEM LTD. Share Price

₹ 223.30

+₹7.05 (3.26%)
1D
Last updated 20 Nov, 2026, 14:48 IST
BSE: 530125
|
Pharmaceuticals

SAMRAT PHARMACHEM LTD. Share Price Today

As of 22 Nov 2026, SAMRAT PHARMACHEM LTD. share price is ₹223.30. The stock opened at ₹215.90, compared to its previous close of ₹216.25. During today's trading session, SAMRAT PHARMACHEM LTD. share price moved in the range of ₹210.20 to ₹224.90, with an average price of ₹217.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹190.00 and a high of ₹298.00.

Share price over the last 1 day rose from 217.00 to 223.30, ranging between 210.20 and 224.90.

₹210.20
3.26% up today
₹224.90
1D LOW
1D HIGH

SAMRAT PHARMACHEM LTD. Stock Insights

Stock Performance
UnderperformingUnderperforming Nifty by 16.43 % in last 1 yr
SAMRAT PHARMACHEM LTD. stock performance
Open₹215.90
High₹224.90
Low₹210.20
Prev. close₹216.25
SAMRAT PHARMACHEM LTD. trading activity
Volume387
Average traded price₹216.20
Last traded time02:48:52 20 Nov
Last traded quantity1

Circuit
L
H
₹212.15
₹234.45
52-week
L
H
₹190.00
₹298.00
Mkt Cap Cr
68.99

P/E
-58.61

P/B
0.99

ROA
-0.9%
ROE
-1.7%

ROCE
-0.41%

Quick Ratio
1.08

EV/EBITDA
194.59

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Samrat Pharma has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Samrat Pharma appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,52,298.6441.175.079.61%13.79%18.65%2.3123.87
Divis Laboratories2,97,324.8188.4116.5215.31%18.69%23.83%3.559.25
Torrent Pharmaceuticals1,78,727.2585.159.734.7%11.42%11.37%0.7534.12
Laurus Labs1,24,001.6593.0720.4611.58%22.11%20.91%0.6852.29
Zydus Lifesciences1,19,206.7027.714.297.63%15.1%14.86%0.9116.06
Dr. Reddy's Laboratories1,16,144.5142.092.994.79%7.21%8.58%1.3519.73
Cipla1,14,312.1240.063.236.6%8.18%10.8%2.521.64
Mankind Pharma1,09,869.9948.546.257.82%12.76%14.68%0.7426.67
Aurobindo Pharma1,03,297.5925.912.626.46%10.13%12.76%1.1512.53
Lupin91,915.8917.63.8213.08%21.65%24.54%1.4210.32

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

SAMRAT PHARMACHEM LTD. Company Background

ISIN
INE103E01016
Sector Market Cap
₹ 68.99 Cr

Samrat Pharmachem Limited is an India-based manufacturer of iodine salts. The Company is engaged in the business of pharmaceutical chemicals. Its products include 3-5 Di Iodosalicylic Acid, Ammonium Iodide, Cadmium Iodide, Calcium Iodate, Clioquinol, Copper Iodide, Ethyl Iodide, Ethylenediamine Dihydroiodide, Hydroiodic Acid 57%, Iodine, Iodine Monochloride, Iodine Monochloride, Iodoquinol, Methyl Iodide, N-Iodo Succinimide, Periodic Acid, Potassium Iodate, Potassium Iodide, Potassium Metaper Iodate, Povidone Iodine, Selenium Dioxide, Sodium Iodate, Sodium Iodide, Sodium Metaper Iodate. These products are offered for the agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, painting and textile industries. The Company exports its products to geographics such as the United States, Europe, Africa, Asia, the Middle East and others.

SAMRAT PHARMACHEM LTD. Financial Highlights

  • Revenue: SAMRAT PHARMACHEM LTD. reported revenue of ₹290.55 crore in FY26 vs ₹286.83 crore in FY25. It showed an increase of 1.30% on a yearly basis.
  • Operating Profit: SAMRAT PHARMACHEM LTD. reported an operating loss of ₹2.98 crore in FY26 vs ₹9.89 crore in FY25. It showed a decrease of 130.13% on a year-on-year basis.
  • Net Profit: SAMRAT PHARMACHEM LTD. reported a net loss of ₹3.31 crore in FY26 vs ₹7.11 crore in FY25. It showed a decrease of 146.55% on a yearly basis.

SAMRAT PHARMACHEM LTD. Quarterly Result Highlights

  • SAMRAT PHARMACHEM LTD. reported revenue of ₹66.17 crore in Sep 2026, compared with ₹80.75 crore in Jun 2026, representing a decrease of 18.06% on a quarter-on-quarter (QoQ) basis.
  • SAMRAT PHARMACHEM LTD. reported an operating profit of ₹0.04 crore in Sep 2026, compared with ₹1.59 crore in Jun 2026, representing a decrease of 97.48% on a quarter-on-quarter (QoQ) basis.
  • SAMRAT PHARMACHEM LTD. reported a profit of ₹0.44 crore in Sep 2026, compared with ₹0.88 crore in Jun 2026, reflecting a decrease of 50.00% on a QoQ basis.
  • The earnings per share (EPS) of SAMRAT PHARMACHEM LTD. stood at ₹10.72 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
49.09%
FII
3.24%
Other DII
0.00%
Retail and other
47.67%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20253.24%
Mar 20263.24%
Jun 20263.24%
Sep 20263.24%

SAMRAT PHARMACHEM LTD. Investment Returns

1 day
+3.26%

1 week
-14.25%

1 month
-17.34%

1 year
-18.55%

3 years
-39.55%

5 years
-10.30%

SAMRAT PHARMACHEM LTD. Share Price History

SAMRAT PHARMACHEM LTD. share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
20 Nov 26
₹215.90 / ₹223.30
+3.26%
19 Nov 26
₹220.00 / ₹216.25
-4.02%
18 Nov 26
₹223.35 / ₹225.30
-4.15%
17 Nov 26
₹235.05 / ₹235.05
-4.99%
Show more

SAMRAT PHARMACHEM LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹289.72₹285.86₹281.58₹310.65
Other Income₹0.83₹0.97₹1.38₹0.48
Total Revenue₹290.55₹286.83₹282.97₹311.12
Total Expenses₹293.54₹276.95₹280.45₹288.59
Profit Before Tax-₹2.98₹9.89₹2.52₹22.53
Tax₹0.33₹2.77₹0.36₹5.90
Profit After Tax-₹3.31₹7.11₹2.16₹16.63
EPS - Basic-₹10.72₹23.02₹7.00₹53.83
EPS - Diluted-₹10.72₹23.02₹7.00₹53.83

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹2.98₹9.89₹2.52₹22.53
Income before WC changes-₹1.89₹10.53₹2.55₹24.18
Change in Assets₹5.91-₹10.01-₹5.75-₹32.20
Change in Liabilities₹6.39-₹9.16₹15.58₹8.09
Change in WC₹12.30-₹19.17₹9.83-₹24.12
Cash flow from Operations₹8.88-₹10.09₹9.41-₹9.44
Cash flow from Investing-₹2.57₹0.00-₹0.41-₹3.00
Cash flow from Financing-₹0.47₹0.48-₹11.20₹9.60
Total Cash Flow₹5.83-₹9.62-₹2.19-₹2.84
Cash (Start of the year)₹0.05₹9.67₹11.86₹14.71
Cash (End of the year)₹5.88₹0.05₹9.67₹11.86

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹20.63₹18.13₹19.17₹17.54
Current Assets₹103.79₹103.36₹102.57₹99.05
Total Assets₹124.42₹121.49₹121.74₹116.59
Current Liabilities₹55.82₹49.58₹56.40₹53.19
Net Current Asset₹47.96₹53.78₹46.16₹45.86
Non-Current Liabilities₹0.41₹0.11₹0.34₹0.25
Equity Capital₹68.18₹71.80₹65.00₹63.14
Total Equity & Liabilities₹124.42₹121.49₹121.74₹116.59
* All values are in INR Crore
SAMRAT PHARMACHEM LTD. market depth
Bid quantityBid priceAsk priceAsk quantity
00223.325
0000
0000
0000
0000
Total bid quantity0
Total ask quantity25
SAMRAT PHARMACHEM LTD. technical summary
Bearish indicators2
Neutral indicators5
Bullish indicators1
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
36.42
Neutral

ATR (14)
13.91
Neutral

STOCH(9,6)
24.65
Neutral

STOCH RSI (14)
19.63
Bullish

ADX(9)
27.83
Bearish

UO(9)
37.11
Neutral

ROC(12)
-16.68
Bearish

WillR(14)
-79.78
Neutral
Period
Simple value
Exponential vaue

5D
229.46
229.37

10D
243.46
238.82

20D
254.25
246.4

50D
244.96
246.77

100D
245.32
241.28
Volume trend — traded volume by day
20 Nov0L
19 Nov0L
18 Nov0L
17 Nov0L
16 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

SAMRAT PHARMACHEM LTD.
Pharmaceuticals
Add Stock
Add Another

SAMRAT PHARMACHEM LTD. Returns Calculator

SAMRAT PHARMACHEM LTD. Share Price FAQs












Please be aware that SAMRAT PHARMACHEM LTD. stock prices are subject to continuous fluctuations due to various factors.